v3.22.2.2
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Warrants
Other Comprehensive Gain (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   262,063,461        
Beginning balance at Dec. 31, 2020 $ 286,380 $ 2,650 $ 2,308,578 $ 12,387 $ 8,227 $ (2,045,462)
Increase (Decrease) in Stockholders' Equity            
Stock options exercised, net (in shares)   1,171,279        
Stock options exercised, net 8,357 $ 12 8,345      
Vesting of restricted stock units, net of taxes (in shares)   1,026,337        
Vesting of restricted stock units, net of taxes (14,700)   (14,700)      
Stock-based compensation 43,931   43,931      
Warrants exercised (in shares)   2,554,999        
Warrants exercised 19,230 $ 26 31,591 (12,387)    
Equity component of the convertible notes (in shares)   472,356        
Equity component of the convertible notes 2,661 $ 5 2,656      
Common stock issued from equity financing and pre-funded warrants (in shares)   11,296,660        
Common stock issued from equity financing and pre-funded warrants 199,747 $ 112 199,552 83    
Unrealized gain (loss) on available-for-sale securities 1       1  
Foreign currency translation adjustment (1,795)       (1,795)  
Net loss (167,183)         (167,183)
Ending balance (in shares) at Sep. 30, 2021   278,585,092        
Ending balance at Sep. 30, 2021 376,629 $ 2,805 2,579,953 83 6,433 (2,212,645)
Beginning balance (in shares) at Jun. 30, 2021   266,532,536        
Beginning balance at Jun. 30, 2021 213,910 $ 2,685 2,364,494 0 9,082 (2,162,351)
Increase (Decrease) in Stockholders' Equity            
Stock options exercised, net (in shares)   248,617        
Stock options exercised, net 1,696 $ 3 1,693      
Vesting of restricted stock units, net of taxes (in shares)   39,007        
Vesting of restricted stock units, net of taxes (262)   (262)      
Stock-based compensation 11,841   11,841      
Equity component of the convertible notes (in shares)   468,272        
Equity component of the convertible notes 2,640 $ 5 2,635      
Common stock issued from equity financing and pre-funded warrants (in shares)   11,296,660        
Common stock issued from equity financing and pre-funded warrants 199,747 $ 112 199,552 83    
Unrealized gain (loss) on available-for-sale securities (11)       (11)  
Foreign currency translation adjustment (2,638)       (2,638)  
Net loss (50,294)         (50,294)
Ending balance (in shares) at Sep. 30, 2021   278,585,092        
Ending balance at Sep. 30, 2021 $ 376,629 $ 2,805 2,579,953 83 6,433 (2,212,645)
Beginning balance (in shares) at Dec. 31, 2021 278,912,800 278,912,800        
Beginning balance at Dec. 31, 2021 $ 307,369 $ 2,808 2,595,419 83 4,981 (2,295,922)
Increase (Decrease) in Stockholders' Equity            
Stock options exercised, net (in shares) 511,000 506,823        
Stock options exercised, net $ 3,191 $ 5 3,186      
Vesting of restricted stock units, net of taxes (in shares)   1,467,513        
Vesting of restricted stock units, net of taxes (11,119)   (11,119)      
Stock-based compensation 57,886   57,886      
Unrealized gain (loss) on available-for-sale securities (84)       (84)  
Foreign currency translation adjustment (43,975)       (43,975)  
Net loss $ (180,703)         (180,703)
Ending balance (in shares) at Sep. 30, 2022 280,887,136 280,887,136        
Ending balance at Sep. 30, 2022 $ 132,565 $ 2,813 2,645,372 83 (39,078) (2,476,625)
Beginning balance (in shares) at Jun. 30, 2022   280,456,667        
Beginning balance at Jun. 30, 2022 173,425 $ 2,811 2,631,110 83 (17,240) (2,443,339)
Increase (Decrease) in Stockholders' Equity            
Stock options exercised, net (in shares)   172,118        
Stock options exercised, net 1,333 $ 2 1,331      
Vesting of restricted stock units, net of taxes (in shares)   258,351        
Vesting of restricted stock units, net of taxes (1,841)   (1,841)      
Stock-based compensation 14,772   14,772      
Unrealized gain (loss) on available-for-sale securities 283       283  
Foreign currency translation adjustment (22,121)       (22,121)  
Net loss $ (33,286)         (33,286)
Ending balance (in shares) at Sep. 30, 2022 280,887,136 280,887,136        
Ending balance at Sep. 30, 2022 $ 132,565 $ 2,813 $ 2,645,372 $ 83 $ (39,078) $ (2,476,625)